Associate Professor of Urology, Associate Professor of Oncology, Associate Professor of Surgery, Johns Hopkins University School of Medicine
Urology
Dr. Trinity J. Bivalacqua, MD
|
|
Give Review
Trinity Bivalacqua works in the field of Urology. He went to Tulane University School of Medicine. He has 1 awards "CMS Meaningful Use Stage 1 Certification". Trinity Bivalacqua is also published. He has 101 publications published. The lastest publication: "Blood Transfusion is Associated with Increased Perioperative Morbidity and Adverse Oncologic Outcomes in Bladder Cancer Patients Receiving Neoadjuvant Chemotherapy and...' Trinity J. Bivalacqua accepts all Medicare patients.
Publications
- New Strategies in Bladder Cancer: A Second Coming for Immunotherapy.
- Do Ultrasensitive Prostate Specific Antigen Measurements Have a Role in Predicting Long-Term Biochemical Recurrence-Free Survival in Men after Radical Prostatectomy?
- Immune checkpoint inhibitors: a new frontier in Bladder cancer.
- Human papillomavirus Infection and immunohistochemical p16(INK4a) expression as predictors of outcome in penile squamous cell carcinomas.
- Involvement of Epigenetics and EMT-Related miRNA in Arsenic-Induced Neoplastic Transformation and Their Potential Clinical Use.
- Tissue-engineered Urinary conduits.
- Inflatable Penile prosthesis technique and outcomes after radial forearm free flap neophalloplasty.
- Mini Review: Pathophysiology of Erectile Dysfunction.
- Temporal changes in neurotrophic factors and neurite outgrowth in the major pelvic ganglion following cavernous nerve injury.
- Utility of uroplakin II expression as a marker of urothelial carcinoma.
- Cyclin A1 expression predicts progression in pT1 urothelial carcinoma of Bladder: a tissue microarray study of 149 patients treated by transurethral resection.
- Robotic surgery in urological oncology: patient care or market share?
- Management of priapism: an update for clinicians.
- Outcomes of men with an Elevated prostate-specific antigen (PSA) level as their sole preoperative intermediate- or high-risk feature.
- Understanding and targeting the Rho kinase pathway in Erectile dysfunction.
- An epigenetic marker panel for recurrence risk prediction of low grade papillary urothelial cell carcinoma (LGPUCC) and its potential use for surveillance after transu...
- Epigenetic inactivation of VGF associated with Urothelial Cell Carcinoma and its potential as a non-invasive biomarker using Urine.
- GATA3 expression in small cell carcinoma of Bladder and prostate and its potential role in determining primary tumor origin.
- Valproic Acid Prevents Penile Fibrosis and Erectile Dysfunction in Cavernous Nerve-Injured Rats.
- Penile straightening maneuvers employed during Penile prosthesis surgery: technical options and outcomes.
- High-dose-rate intraoperative radiation therapy: the nuts and bolts of starting a program.
- Impact of hospital volume on perioperative outcomes and costs of radical cystectomy: analysis of the Maryland Health Services Cost Review Commission database.
- Identification of men with the highest risk of early disease recurrence after radical Prostatectomy.
- Sexual Dysfunction: First EAU priapism treatment guidelines published.
- Combined inflatable Penile prosthesis-artificial urinary sphincter implantation: no increased risk of adverse events compared to single or staged device implantation.
- Sildenafil Promotes eNOS Activation and Inhibits NADPH Oxidase in the Transgenic Sickle Cell Mouse Penis.
- Very-high-risk localized prostate Cancer: definition and outcomes.
- Renal cell carcinoma presenting with brain metastasis from a 1.6 cm primary tumor.
- Pathological and oncologic outcomes for men with positive lymph nodes at radical Prostatectomy: The Johns Hopkins Hospital 30-year experience.
- Comparison of biochemical recurrence-free survival between periprostatic and pelvic lymph node metastases of prostate Cancer.
- Trends in immediate perioperative morbidity and delay in discharge after open and minimally invasive radical Prostatectomy (RP): a 20-year institutional experience.
- Nightly vs on-demand sildenafil for penile rehabilitation after minimally invasive nerve-sparing radical Prostatectomy: results of a randomized double-blind trial with...
- Corporal Burnett "Snake" surgical maneuver for the treatment of ischemic priapism: long-term followup.
- Inhibition of Rho-kinase improves Erectile function, increases nitric oxide signaling and decreases penile apoptosis in a rat model of cavernous nerve injury.
- Radical cystectomy in patients with preexisting three-piece inflatable Penile prosthesis.
- Standard operational procedures for low sexual desire in men.
- Contemporaneous comparison of open vs minimally-invasive radical prostatectomy for high-risk prostate Cancer.
- Radial Forearm Free Flap Phalloplasty for Penile Inadequacy in Exstrophy Patients.
- Inhibition of sympathetic neuroeffector transmission in Human corpus cavernosum.
- Ureteral Stents Placed at the Time of Urinary Diversion Decreases Postoperative Morbidity.
- Medical management of ischemic stuttering priapism: a contemporary review of the literature.
- Smoking Knowledge Assessment and Cessation Trends in Patients With Bladder Cancer Presenting to a Tertiary Referral Center.
- Arginase inhibition promotes wound healing in mice.
- Management of Primary Squamous Cell Carcinoma at the Mucocutaneous Junction of an Ileal Conduit.
- Metabolomics and Bladder cancer.
- Metabolomics and urologic oncology.
- Endorectal T2-weighted MRI does not differentiate between favorable and adverse pathologic features in men with prostate Cancer who would qualify for active surveillance.
- New Insights into the Pathophysiology of Sickle Cell Disease-Associated Priapism.
- Priapism: new concepts in medical and surgical management.
- Post-translational inactivation of endothelial nitric oxide synthase in the transgenic sickle cell mouse penis.
- DAILY PHOSPHODIESTERASE TYPE-5 INHIBITOR THERAPY AS RESCUE FOR RECURRENT ISCHEMIC PRIAPISM AFTER FAILED ANDROGEN ABLATION: A CASE REPORT.
- Activated RhoA/Rho kinase impairs Erectile function after cavernous nerve injury in rats.
- Long Term-Survival after Radical Prostatectomy for men with High Gleason Sum.
- Long-term survival after radical Prostatectomy for men with high Gleason sum in pathologic specimen.
- Attenuated RhoA/Rho-kinase signaling in penis of transgenic sickle cell mice.
- Post-translational regulation of endothelial nitric oxide synthase (eNOS) by estrogens in the rat vagina.
- Priapism: pathogenesis, epidemiology, and management.
- The presence of circulating tumor cells does not predict extravesical disease in Bladder cancer patients prior to radical cystectomy.
- Pathological upstaging during radical cystectomy is associated with worse recurrence-free survival in patients with bacillus Calmette-Guerin-refractory Bladder cancer.
- Arginase inhibition restores NOS coupling and reverses endothelial Dysfunction and vascular stiffness in old rats.
- Establishment of a transgenic sickle-cell mouse model to study the pathophysiology of priapism.
- Posttranslational modification of constitutive nitric oxide synthase in the penis.
- Endothelial nitric oxide synthase regulation in female genital Tract structures.
- Sildenafil inhibits superoxide formation and prevents endothelial dysfunction in a mouse model of secondhand smoke induced Erectile dysfunction.
- Serum biomarker measurements of endothelial function and oxidative stress after daily dosing of sildenafil in type 2 diabetic men with Erectile dysfunction.
- Presentation and management of a patient with subcutaneous metastatic transitional cell carcinoma of the Bladder.
- Application of Evicel to cavernous nerves of the rat does not influence Erectile function in vivo.
- Erythropoietin promotes erection recovery after nerve-sparing radical retropubic Prostatectomy: a retrospective analysis.
- Intraperitoneal effects of extraperitoneal laparoscopic radical Prostatectomy.
- Cystoscopic management of an extruded coil from arteriovenous fistula embolization using arthroscopic instruments.
- The use of gene transfer technology to study the pathophysiology of Erectile dysfunction.
- Glucose-6-phosphate dehydrogenase deficiency: an etiology for idiopathic priapism?
- Priapism: current principles and practice.
- Analysis of vasodilator responses to peroxynitrite in the hindlimb vascular bed of the cat.
- Paraneoplastic polyarthritis from non-small-cell lung cancer metastatic to the Bladder.
- Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability.
- Overexpression of arginase in the aged mouse penis impairs Erectile function and decreases eNOS activity: influence of in vivo gene therapy of anti-arginase.
- Mesenchymal stem cells alone or ex vivo gene modified with endothelial nitric oxide synthase reverse age-associated Erectile dysfunction.
- Feasibility of the use of phosphodiesterase type 5 inhibitors in a pharmacologic prevention program for recurrent priapism.
- Priapism: new concepts in the pathophysiology and new treatment strategies.
- Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism.
- The breakdown of preformed advanced glycation end products reverses Erectile dysfunction in streptozotocin-induced diabetic rats: preventive versus curative treatment.
- Elevated RhoA/Rho-kinase activity in the aged rat penis: mechanism for age-associated erectile dysfunction.
- Poly(Adenosine diphosphate-ribose) polymerase inhibition preserves Erectile function in rats after cavernous nerve injury.
- Vasoactive prostanoids are generated from arachidonic acid by COX-1 and COX-2 in the mouse.
- Superoxide anion production in the rat penis impairs Erectile function in diabetes: influence of in vivo extracellular superoxide dismutase gene therapy.
- Neurohumoral features of myocardial stunning due to sudden emotional stress.
- Phosphodiesterase-5A dysregulation in penile Erectile tissue is a mechanism of priapism.
- Stratification of penile vascular pathologies in patients with Peyronie's Disease and in men with erectile dysfunction according to age: a comparative study.
- RhoA/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: a mechanism for diabetes-associated Erectile dysfunction.
- Re: optimizing treatment for diabetes mellitus induced Erectile dysfunction.
- Relationship between the severity of penile curvature and the presence of comorbidities in men with Peyronie's Disease.
- Engineering ex vivo-expanded marrow stromal cells to secrete calcitonin gene-related peptide using adenoviral vector.
- Intralesional interferon-alpha-2B injections for the treatment of Peyronie's Disease.
- Gene therapy techniques for the delivery of endothelial nitric oxide synthase to the corpora cavernosa for Erectile dysfunction.
- Endothelial dysfunction in erectile dysfunction: role of the endothelium in erectile physiology and Disease.
- Adenoviral gene transfer of eNOS: high-level expression in ex vivo expanded marrow stromal cells.
- The protective effect of aminoguanidine on Erectile function in streptozotocin diabetic rats.
- Role of cyclooxygenase-2 in the generation of vasoactive prostanoids in the rat pulmonary and systemic vascular beds.
- Blood Transfusion is Associated with Increased Perioperative Morbidity and Adverse Oncologic Outcomes in Bladder Cancer Patients Receiving Neoadjuvant Chemotherapy and...
Schools
Tulane Univ Sch Of Med
Procedures Preformed
- AdRenalectomy
- Cystectomy
- Cystometry
- Cystotomy
- View All
Conditions Treated
- Bladder Cancer
- Bladder Infection
- Bladder Stones
- Blood in Urine (Hematuria)
- View All
Doctors Specialties
- Urology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Johns Hopkins University -
Tulane University School of Medicine
Hospital
-
Johns Hopkins Bayview Medical Center -
Johns Hopkins Hospital
Drug Facts
| NPI NUMBER | 1265579254 | |
| NPPES Provider LastName | BIVALACQUA | |
| NPPES Provider FirstName | TRINITY | |
| NPPES Provider ZIPCode | 21287 | |
| NPPES Provider State | MD | |
| Specialty Description | Urology | |
| Total Claim Count | 129.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1265579254 |
| Last Name Of The Provider | BIVALACQUA |
| First Name Of The Provider | TRINITY |
| View All |
Similar Doctors
|
|
Dr. Michael L. Levin, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lawrence C. Bezirdjian, MD |
|
|
Dr. Rainer M. Engel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert A. Thompson Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Suhayl S. Kalash, MD |
|
|
Dr. Brian R. Matlaga, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Ray Stutzman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael J. Naslund, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gautham R. Churukanti, MD |
|
|
Dr. Michael H. Johnson, MD |
|
|
Dr. David D. Rich, MD |
|
|
Dr. Nikhil Waingankar, MD |
|
|
Dr. Kofi E. Shaw-Taylor, MD
This Doctor is OpenDoctor Recommended.
|